Nipah: The looming post-covid pandemic
Bioinformation. 2024 Jan 31;20(1):1-3. doi: 10.6026/973206300200001. eCollection 2024.ABSTRACTFirst identified as a pathogen in Malaysia and Singapore in 1999, Nipah virus (NiV) caused nearly 300 human cases and over 100 fatalities. It also killed about 1 million pigs. Three years later (2002), it was reported in Pteropus bats in Malaysia, in Cambodia & Thailand, (2005), and as far as Madagascar (2007) and Ghana (2008). India (Kerala) reported its first human NiV-caused fatalities in September 2023. Taken together, these trends emphasize its public health threat. In humans, NiV infection initially leads to fever, heada...
Source: Bioinformation - February 14, 2024 Category: Bioinformatics Authors: Olivia Sekimoto Francesco Chiappelli Source Type: research

Nipah: The looming post-covid pandemic
Bioinformation. 2024 Jan 31;20(1):1-3. doi: 10.6026/973206300200001. eCollection 2024.ABSTRACTFirst identified as a pathogen in Malaysia and Singapore in 1999, Nipah virus (NiV) caused nearly 300 human cases and over 100 fatalities. It also killed about 1 million pigs. Three years later (2002), it was reported in Pteropus bats in Malaysia, in Cambodia & Thailand, (2005), and as far as Madagascar (2007) and Ghana (2008). India (Kerala) reported its first human NiV-caused fatalities in September 2023. Taken together, these trends emphasize its public health threat. In humans, NiV infection initially leads to fever, heada...
Source: Bioinformation - February 14, 2024 Category: Bioinformatics Authors: Olivia Sekimoto Francesco Chiappelli Source Type: research

Nipah: The looming post-covid pandemic
Bioinformation. 2024 Jan 31;20(1):1-3. doi: 10.6026/973206300200001. eCollection 2024.ABSTRACTFirst identified as a pathogen in Malaysia and Singapore in 1999, Nipah virus (NiV) caused nearly 300 human cases and over 100 fatalities. It also killed about 1 million pigs. Three years later (2002), it was reported in Pteropus bats in Malaysia, in Cambodia & Thailand, (2005), and as far as Madagascar (2007) and Ghana (2008). India (Kerala) reported its first human NiV-caused fatalities in September 2023. Taken together, these trends emphasize its public health threat. In humans, NiV infection initially leads to fever, heada...
Source: Bioinformation - February 14, 2024 Category: Bioinformatics Authors: Olivia Sekimoto Francesco Chiappelli Source Type: research

Nipah: The looming post-covid pandemic
Bioinformation. 2024 Jan 31;20(1):1-3. doi: 10.6026/973206300200001. eCollection 2024.ABSTRACTFirst identified as a pathogen in Malaysia and Singapore in 1999, Nipah virus (NiV) caused nearly 300 human cases and over 100 fatalities. It also killed about 1 million pigs. Three years later (2002), it was reported in Pteropus bats in Malaysia, in Cambodia & Thailand, (2005), and as far as Madagascar (2007) and Ghana (2008). India (Kerala) reported its first human NiV-caused fatalities in September 2023. Taken together, these trends emphasize its public health threat. In humans, NiV infection initially leads to fever, heada...
Source: Bioinformation - February 14, 2024 Category: Bioinformatics Authors: Olivia Sekimoto Francesco Chiappelli Source Type: research

Nipah: The looming post-covid pandemic
Bioinformation. 2024 Jan 31;20(1):1-3. doi: 10.6026/973206300200001. eCollection 2024.ABSTRACTFirst identified as a pathogen in Malaysia and Singapore in 1999, Nipah virus (NiV) caused nearly 300 human cases and over 100 fatalities. It also killed about 1 million pigs. Three years later (2002), it was reported in Pteropus bats in Malaysia, in Cambodia & Thailand, (2005), and as far as Madagascar (2007) and Ghana (2008). India (Kerala) reported its first human NiV-caused fatalities in September 2023. Taken together, these trends emphasize its public health threat. In humans, NiV infection initially leads to fever, heada...
Source: Bioinformation - February 14, 2024 Category: Bioinformatics Authors: Olivia Sekimoto Francesco Chiappelli Source Type: research

Nipah: The looming post-covid pandemic
Bioinformation. 2024 Jan 31;20(1):1-3. doi: 10.6026/973206300200001. eCollection 2024.ABSTRACTFirst identified as a pathogen in Malaysia and Singapore in 1999, Nipah virus (NiV) caused nearly 300 human cases and over 100 fatalities. It also killed about 1 million pigs. Three years later (2002), it was reported in Pteropus bats in Malaysia, in Cambodia & Thailand, (2005), and as far as Madagascar (2007) and Ghana (2008). India (Kerala) reported its first human NiV-caused fatalities in September 2023. Taken together, these trends emphasize its public health threat. In humans, NiV infection initially leads to fever, heada...
Source: Bioinformation - February 14, 2024 Category: Bioinformatics Authors: Olivia Sekimoto Francesco Chiappelli Source Type: research

Nipah: The looming post-covid pandemic
Bioinformation. 2024 Jan 31;20(1):1-3. doi: 10.6026/973206300200001. eCollection 2024.ABSTRACTFirst identified as a pathogen in Malaysia and Singapore in 1999, Nipah virus (NiV) caused nearly 300 human cases and over 100 fatalities. It also killed about 1 million pigs. Three years later (2002), it was reported in Pteropus bats in Malaysia, in Cambodia & Thailand, (2005), and as far as Madagascar (2007) and Ghana (2008). India (Kerala) reported its first human NiV-caused fatalities in September 2023. Taken together, these trends emphasize its public health threat. In humans, NiV infection initially leads to fever, heada...
Source: Bioinformation - February 14, 2024 Category: Bioinformatics Authors: Olivia Sekimoto Francesco Chiappelli Source Type: research

Nipah: The looming post-covid pandemic
Bioinformation. 2024 Jan 31;20(1):1-3. doi: 10.6026/973206300200001. eCollection 2024.ABSTRACTFirst identified as a pathogen in Malaysia and Singapore in 1999, Nipah virus (NiV) caused nearly 300 human cases and over 100 fatalities. It also killed about 1 million pigs. Three years later (2002), it was reported in Pteropus bats in Malaysia, in Cambodia & Thailand, (2005), and as far as Madagascar (2007) and Ghana (2008). India (Kerala) reported its first human NiV-caused fatalities in September 2023. Taken together, these trends emphasize its public health threat. In humans, NiV infection initially leads to fever, heada...
Source: Bioinformation - February 14, 2024 Category: Bioinformatics Authors: Olivia Sekimoto Francesco Chiappelli Source Type: research

Nipah: The looming post-covid pandemic
Bioinformation. 2024 Jan 31;20(1):1-3. doi: 10.6026/973206300200001. eCollection 2024.ABSTRACTFirst identified as a pathogen in Malaysia and Singapore in 1999, Nipah virus (NiV) caused nearly 300 human cases and over 100 fatalities. It also killed about 1 million pigs. Three years later (2002), it was reported in Pteropus bats in Malaysia, in Cambodia & Thailand, (2005), and as far as Madagascar (2007) and Ghana (2008). India (Kerala) reported its first human NiV-caused fatalities in September 2023. Taken together, these trends emphasize its public health threat. In humans, NiV infection initially leads to fever, heada...
Source: Bioinformation - February 14, 2024 Category: Bioinformatics Authors: Olivia Sekimoto Francesco Chiappelli Source Type: research

Immunization with a whole cell vaccine reduces pneumococcal nasopharyngeal density and shedding, and middle ear infection in mice
Vaccine. 2024 Feb 12:S0264-410X(24)00131-2. doi: 10.1016/j.vaccine.2024.01.104. Online ahead of print.ABSTRACTPneumococcal Conjugate Vaccines (PCVs) have substantially reduced the burden of disease caused by Streptococcus pneumoniae (the pneumococcus). However, protection is limited to vaccine serotypes, and when administered to children who are colonized with pneumococci at the time of vaccination, immune responses to the vaccine are blunted. Here, we investigate the potential of a killed whole cell pneumococcal vaccine (WCV) to reduce existing pneumococcal carriage and mucosal disease when given therapeutically to infant...
Source: Vaccine - February 13, 2024 Category: Allergy & Immunology Authors: Jayne Manning Sam Manna Eileen M Dunne Viktoria Bongcaron Casey L Pell Natalie L Patterson Sacha D Kuil Poshmaal Dhar David Goldblatt E Kim Mulholland Paul V Licciardi Roy M Robins-Browne Richard Malley Odilia Wijburg Catherine Satzke Source Type: research

Minimal interval for the administration of a pneumococcal polysaccharide vaccine following the administration of a pneumococcal conjugate vaccine
Vaccine. 2024 Feb 12:S0264-410X(24)00163-4. doi: 10.1016/j.vaccine.2024.02.023. Online ahead of print.NO ABSTRACTPMID:38346915 | DOI:10.1016/j.vaccine.2024.02.023 (Source: Vaccine)
Source: Vaccine - February 12, 2024 Category: Allergy & Immunology Authors: Philippe De Wals Micha ël Desjardins Source Type: research

Disparities in Influenza, Pneumococcal, COVID-19 Vaccine Coverage in High-Risk Adults 19-64 Years of Age in Southeastern Minnesota, 2010-2021
Chest. 2024 Feb 9:S0012-3692(24)00145-4. doi: 10.1016/j.chest.2024.01.049. Online ahead of print.ABSTRACTBACKGROUND: Despite effective vaccines against influenza, pneumococcus and COVID-19, uptake has been suboptimal.RESEARCH QUESTION: While disparities in vaccination by race and ethnicity have been observed, what is the role of other sociodemographic in US vaccine uptake?STUDY DESIGN AND METHODS: We conducted a population-based study using Rochester Epidemiology Project (REP), a comprehensive medical records linkage system, to assess effects of sociodemographic factors including race, ethnicity, individual-level socioecon...
Source: Chest - February 11, 2024 Category: Respiratory Medicine Authors: Jamie R Felzer Amy Montgomery Allison M LeMahieu Lila J Finney Rutten Young J Juhn Chung-Il Wi Robert M Jacobson Cassie C Kennedy Source Type: research

Neighborhood-level disadvantages increase risk for invasive pneumococcal disease
CONCLUSIONS: ADI is a risk factor for IPD in younger adults. Community-level socioeconomic risk factors should be considered when developing prevention strategies such as increasing vaccine uptake in high risk population to reduce the disease burden of IPD.PMID:38340982 | DOI:10.1016/j.amjms.2024.02.002 (Source: The American Journal of the Medical Sciences)
Source: The American Journal of the Medical Sciences - February 10, 2024 Category: General Medicine Authors: Daniel Minassian Liang Shan Chaoling Dong Arzoo N Charania Carlos J Orihuela Chao He Source Type: research

Measles vaccination - An underestimated prevention measure: Analyzing a fatal case in Hildesheim, Germany
We describe here an outbreak of measles occurring in Hildesheim. The outbreak comprised 43 cases and lasted 14 weeks. Surprisingly, a high number of vaccination failures was observed since 11 cases had received two doses of the MMR vaccine and 4 additional cases were vaccinated once. A 33-year-old woman passed away during the outbreak. She was the mother of 5 children between 4 and 16 years of age. Two schoolchildren contracted measles and passed it on to the rest of the family. Due to delivery bottlenecks, the vaccination of the mother was delayed. She developed measles-like symptoms 3 days after vaccination and was found...
Source: International Journal of Medical Microbiology - February 9, 2024 Category: Microbiology Authors: Katharina Hueppe Jan Ortman Hannah Gauselmann Sabine Santibanez Annette Mankertz Source Type: research

Surveillance of pneumococcal serotypes in adults hospitalised with acute lower respiratory tract infection in Bristol, UK
DISCUSSION: Among adults hospitalised with respiratory infection, pneumococcus is an important pathogen across all subgroups, including CAP+/RAD- and NP-LRTI. Despite 20-years of PPV23 use in adults ≥ 65-years and herd protection due to 17-years of PCV use in infants, vaccine-serotype pneumococcal disease still causes a significant proportion of LRTI adult hospitalizations. Direct adult vaccination with high-valency PCVs may reduce pneumococcal disease burden.PMID:38336560 | DOI:10.1016/j.vaccine.2024.02.007 (Source: Vaccine)
Source: Vaccine - February 9, 2024 Category: Allergy & Immunology Authors: Catherine Hyams Maria Lahuerta Christian Theilacker Jade King David Adegbite Serena McGuinness Charli Grimes James Campling Jo Southern Michael W Pride Elizabeth Begier Nick Maskell Jennifer Oliver Luis Jodar Bradford D Gessner Adam Finn AvonCAP Research Source Type: research